These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17989351)

  • 1. [3H]Org 43553, the first low-molecular-weight agonistic and allosteric radioligand for the human luteinizing hormone receptor.
    Heitman LH; Oosterom J; Bonger KM; Timmers CM; Wiegerinck PH; Ijzerman AP
    Mol Pharmacol; 2008 Feb; 73(2):518-24. PubMed ID: 17989351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substituted terphenyl compounds as the first class of low molecular weight allosteric inhibitors of the luteinizing hormone receptor.
    Heitman LH; Narlawar R; de Vries H; Willemsen MN; Wolfram D; Brussee J; Ijzerman AP
    J Med Chem; 2009 Apr; 52(7):2036-42. PubMed ID: 19296599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of ovulation by a potent, orally active, low molecular weight agonist (Org 43553) of the luteinizing hormone receptor.
    van de Lagemaat R; Timmers CM; Kelder J; van Koppen C; Mosselman S; Hanssen RG
    Hum Reprod; 2009 Mar; 24(3):640-8. PubMed ID: 19088107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A signaling-selective, nanomolar potent allosteric low molecular weight agonist for the human luteinizing hormone receptor.
    van Koppen CJ; Zaman GJ; Timmers CM; Kelder J; Mosselman S; van de Lagemaat R; Smit MJ; Hanssen RG
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Nov; 378(5):503-14. PubMed ID: 18551279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activation of adenylyl cyclase in rats testes and ovaries using thienopyrimidine derivatives].
    Shpakov AO; Derkach KV; Dar'in DV; Lobanov PS
    Tsitologiia; 2014; 56(5):346-52. PubMed ID: 25696974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of different putative allosteric binding pockets at the lutropin receptor by using diverse drug-like low molecular weight ligands.
    Heitman LH; Kleinau G; Brussee J; Krause G; Ijzerman AP
    Mol Cell Endocrinol; 2012 Apr; 351(2):326-36. PubMed ID: 22269095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function.
    Urwyler S; Pozza MF; Lingenhoehl K; Mosbacher J; Lampert C; Froestl W; Koller M; Kaupmann K
    J Pharmacol Exp Ther; 2003 Oct; 307(1):322-30. PubMed ID: 12954816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
    Baraldi PG; Romagnoli R; Pavani MG; Nuñez Mdel C; Tabrizi MA; Shryock JC; Leung E; Moorman AR; Uluoglu C; Iannotta V; Merighi S; Borea PA
    J Med Chem; 2003 Feb; 46(5):794-809. PubMed ID: 12593659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiloride derivatives and a nonpeptidic antagonist bind at two distinct allosteric sites in the human gonadotropin-releasing hormone receptor.
    Heitman LH; Ye K; Oosterom J; Ijzerman AP
    Mol Pharmacol; 2008 Jun; 73(6):1808-15. PubMed ID: 18344315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor.
    Bianchi BR; El Kouhen R; Neelands TR; Lee CH; Gomtsyan A; Raja SN; Vaidyanathan SN; Surber B; McDonald HA; Surowy CS; Faltynek CR; Moreland RB; Jarvis MF; Puttfarcken PS
    J Pharmacol Exp Ther; 2007 Oct; 323(1):285-93. PubMed ID: 17660385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first orally active low molecular weight agonists for the LH receptor: thienopyr(im)idines with therapeutic potential for ovulation induction.
    van Straten NC; Schoonus-Gerritsma GG; van Someren RG; Draaijer J; Adang AE; Timmers CM; Hanssen RG; van Boeckel CA
    Chembiochem; 2002 Oct; 3(10):1023-6. PubMed ID: 12362369
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
    Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
    Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor.
    Langmead CJ; Jerman JC; Brough SJ; Scott C; Porter RA; Herdon HJ
    Br J Pharmacol; 2004 Jan; 141(2):340-6. PubMed ID: 14691055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional reconstitution of detergent-solubilized bovine calf testis luteinizing hormone/chorionic gonadotropin receptor into phospholipid vesicles.
    Grasso P
    Recept Signal Transduct; 1996; 6(2):53-62. PubMed ID: 9015861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]HEMADO--a novel tritiated agonist selective for the human adenosine A3 receptor.
    Klotz KN; Falgner N; Kachler S; Lambertucci C; Vittori S; Volpini R; Cristalli G
    Eur J Pharmacol; 2007 Feb; 556(1-3):14-8. PubMed ID: 17126322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a thieno[2,3-d]pyrimidine-2,4-dione bearing a p-methoxyureidophenyl moiety at the 6-position: a highly potent and orally bioavailable non-peptide antagonist for the human luteinizing hormone-releasing hormone receptor.
    Sasaki S; Cho N; Nara Y; Harada M; Endo S; Suzuki N; Furuya S; Fujino M
    J Med Chem; 2003 Jan; 46(1):113-24. PubMed ID: 12502365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid ortho/allosteric ligands for the adenosine A(1) receptor.
    Narlawar R; Lane JR; Doddareddy M; Lin J; Brussee J; Ijzerman AP
    J Med Chem; 2010 Apr; 53(8):3028-37. PubMed ID: 20345101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [N-methyl-3H3]AZ10419369 binding to the 5-HT1B receptor: in vitro characterization and in vivo receptor occupancy.
    Maier DL; Sobotka-Briner C; Ding M; Powell ME; Jiang Q; Hill G; Heys JR; Elmore CS; Pierson ME; Mrzljak L
    J Pharmacol Exp Ther; 2009 Jul; 330(1):342-51. PubMed ID: 19401496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, synthesis, and biological evaluation of novel pyrazoles as low molecular weight luteinizing hormone receptor agonists.
    Jorand-Lebrun C; Brondyk B; Lin J; Magar S; Murray R; Reddy A; Shroff H; Wands G; Weiser W; Xu Q; McKenna S; Brugger N
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2080-5. PubMed ID: 17321742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and receptor binding of new thieno[2,3-d]-pyrimidines as selective ligands of 5-HT(3) receptors.
    Modica MN; Romeo G; Salerno L; Pittalà V; Siracusa MA; Mereghetti I; Cagnotto A; Mennini T; Gáspár R; Gál A; Falkay G; Palkó M; Maksay G; Fülöp F
    Arch Pharm (Weinheim); 2008 Jun; 341(6):333-43. PubMed ID: 18535994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.